Related Experiment Video
Updated: May 17, 2026

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
Published on: August 6, 2020
Infants Younger Than 24 Months With Severe Malaria Have a Serologic Profile of Active Infection With Epstein-Barr
Wayne T Cheng1,2,3, Balotin Fogang4, Aarti Jain5
1Department of Infectious Diseases, College of Veterinary Medicine.
Insights
Primary Epstein Barr Virus (EBV) infection in infants may increase the risk of severe malaria. Early EBV targeting could protect young children in malaria-endemic regions from severe falciparum malaria.
Area of Science:
- Immunology
- Infectious Diseases
- Pediatrics
Background:
- Primary Epstein Barr Virus (EBV) infection, typically causing infectious mononucleosis in adolescents, is often asymptomatic in young children in malaria-endemic areas.
- Infants with primary EBV infection experience temporary humoral immune suppression, raising questions about its impact on malaria susceptibility.
- The relationship between EBV infection and severe malaria development in infants remains largely unknown.
Purpose of the Study:
- To investigate whether Epstein Barr Virus (EBV) infection in infants (6-24 months) is associated with an increased risk of severe malaria.
- To analyze the impact of active EBV infection on anti-Plasmodium falciparum (Pf) antibody responses in infants.
Main Methods:
- A cross-sectional study involving 195 infants (6-24 months) in Cameroon.
- Infants were assessed for Plasmodium falciparum (Pf) parasitemia and malaria severity using microscopy/RDT and WHO criteria.
- Epstein Barr Virus (EBV) infection status was determined serologically, and anti-Pf antibody responses (magnitude, breadth, invasion-blocking capacity) were quantified.
Main Results:
- 24% of infants had active Epstein Barr Virus (EBV) infection.
- Children with active EBV infection showed a higher proportion of severe malaria cases.
- Elevated magnitude and breadth of anti-Pf antibody responses with increased invasion-blocking capacity were observed in children with active EBV.
Conclusions:
- Primary Epstein Barr Virus (EBV) infection may serve as a risk factor for severe malaria in infants aged 6-24 months.
- Targeting EBV infection in young children could potentially reduce the incidence of severe falciparum malaria in endemic areas.
Background:
Primary Epstein-Barr virus (EBV) infection occurs during late adolescence and is characterized by the symptomatic manifestation of infectious mononucleosis. Asymptomatic primary EBV infection in malaria-endemic areas often occurs in young children by the age of 2 years. Resulting in humoral immune suppression to unrelated antigenic challenges for approximately 4 weeks.
Methods:
We undertook a cross-sectional study of 195 infants aged 6 to 24 months in Cameroon. The EBV infection status of each child was determined by a standard serologic classification system, and the magnitude, breadth, and invasion-blocking capacity of the anti-Plasmodium falciparum antibody response were quantified.
Results:
An overall 24% of children were serologically positive for active EBV infection, and the highest proportion of severe malaria cases was in children with active EBV. An elevated magnitude and breadth of the antibody response with increased in vitro invasion-blocking capacity were observed in children with active EBV, but circulating parasitemia in vivo was similar.
Conclusions:
Primary EBV infection may be a risk factor for developing severe malaria in children aged 6 to 24 months. Targeting EBV infection in young children may be beneficial in protecting against the development of severe falciparum malaria in children living in malaria-endemic areas.
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Viral Meningitis
Encephalitis l: Introduction
Cytomegalovirus Disease
Bacterial Meningitis I: Introduction
Symbiosis

